Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
related decrease » reported decrease (Expand Search), greater decrease (Expand Search), related degree (Expand Search)
related disease » related diseases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
related decrease » reported decrease (Expand Search), greater decrease (Expand Search), related degree (Expand Search)
related disease » related diseases (Expand Search)
-
3761
-
3762
-
3763
-
3764
-
3765
-
3766
-
3767
Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver Fibrosis
Published 2025Subjects: -
3768
Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver Fibrosis
Published 2025Subjects: -
3769
-
3770
Bi-directional MR results for the four metabolites significant in the interaction QTL analysis.
Published 2024Subjects: -
3771
Effect of ex vivo treatment with rhTGFβ1 or a TGFβ1 inhibitor on monocyte responses to rgE stimulation. Monocytes and NK cells purified from PBMC collected from 10 RZV recipients (demographics in S4 Table) before vaccination (D0) and 90 days post-vaccination (D90) were combined ex vivo and stimulated with VZV-rgE. A subset of D0 monocyte & NK cocultures was also treated with the TGFβ1 inhibitor LY (D0 LY), and a subset of D90 cocultures were supplemented with rhTGFβ1. The graph shows individual data points, means and p values calculated by Friedman test for repeated measures with FDR correction. LY treatment of cells collected on D0 significantly increased their activation to levels similar to D90. Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.
Published 2025“…Conversely, treatment of D90 cells with rhTGFβ1 significantly decreased their activation to levels similar to D0.…”
-
3772
-
3773
-
3774
-
3775
-
3776
-
3777
-
3778
-
3779
-
3780